抗生素使用作为肠易激综合征的危险因素:一项全国性病例对照研究结果
该研究基于瑞典全国队列的病例对照设计,纳入2007至2016年确诊的29111例成人肠易激综合征(IBS)患者与135172名对照,分析抗生素使用与IBS的关联。结果显示,诊断前1年内使用抗生素者IBS风险升高(OR 2.21,95%CI 2.14-2.28),且风险随抗生素配发次数增加而升高。
要点
- IBS患者诊断前1年内抗生素使用率为74.9%,高于对照的57.8%。
- 多变量调整后,既往抗生素使用与IBS风险升高相关(OR 2.21,95%CI 2.14-2.28)。
- 与未使用相比,1-2次和≥3次抗生素配发均与IBS风险升高相关,且呈剂量趋势(P<0.001)。
核心结论
- 既往抗生素使用与肠易激综合征风险升高相关,其中多次抗生素配发者风险最高。
研究设计与样本
- 全国性病例对照研究,基于瑞典组织病理学队列、患者登记和处方药登记,纳入29111例成人IBS患者及按年龄、性别、县和日历年匹配的135172名对照。
主要发现
- IBS患者诊断前1年内抗生素使用率为74.9%,高于对照的57.8%。
- 多变量调整后,抗生素使用与IBS风险的OR为2.21(95%CI 2.14-2.28),该关联不因年龄、性别、IBS诊断年份或IBS亚型而异。
- 与未使用抗生素相比,1-2次配发的OR为1.67(95%CI 1.61-1.73),≥3次配发的OR为3.36(95%CI 3.24-3.49),趋势检验P<0.001,且不限于特定抗生素类别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The microbiome plays an important role in the pathophysiology of irritable bowel syndrome (IBS). Antibiotic use can fundamentally alter gut microbial ecology. We examined the association of antibiotic use with IBS in a large population-based investigation. METHODS: A case-control study with prospectively collected data on 29,111 adult patients diagnosed with IBS in Sweden between 2007 and 2016 matched with 135,172 controls. Using a comprehensive histopathology cohort, the Swedish Patient Register, and the Prescribed Drug Register, we identified all consecutive cases of IBS in addition to cumulative antibiotic dispensations accrued until 1 year prior to IBS (exclusionary period) for cases and time of matching for up to five general population controls matched on the basis of age, sex, country and calendar year. Conditional logistic regression estimated multivariable-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the risk of IBS. RESULTS: Patients with IBS (n = 29,111) were more likely than controls (n = 135,172) to have used antibiotics up to 1 year prior to diagnosis (74.9% vs. 57.8%). After multivariable adjustment, this translated to a more than twofold increased odds of IBS (OR 2.21, 95% CI 2.14-2.28) that did not differ according to age, sex, year of IBS diagnosis or IBS subtype. Compared to none, 1-2 (OR 1.67, 95% CI 1.61-1.73) and ≥3 antibiotics dispensations (OR 3.36, 95% CI 3.24-3.49) were associated with increased odds of IBS (p for trend <0.001) regardless of the antibiotic class. CONCLUSIONS: Prior antibiotics use was associated with an increased odds of IBS with the highest risk among people with multiple antibiotics dispensations.
引用
- Staller K, Olén O, Söderling J, et al. Antibiotic use as a risk factor for irritable bowel syndrome: Results from a nationwide, case-control study. Aliment Pharmacol Ther. 2023. PMID: 37771273. doi:10.1111/apt.17736
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。